Temasek Holdings’s Pfizer PFE Stock Holding History

Temasek Holdings’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-520,900	Closed	-$12.6M	–	147
2025 Q2	$12.6M	Hold	520,900	–	–	0.05%	98
2025 Q1	$13.2M	Buy	+520,900	New	+$13.6M	0.05%	94

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Temasek Holdings's PFE Position: Q3 2025 in Review

Temasek Holdings sold out of Pfizer (PFE) in Q3 2025, closing a stake of 520,900 shares — an estimated $12.6M sold.

Temasek Holdings first reported a position in PFE in Q1 2025 and held it in 2 quarters. The position peaked at $13.2M in Q1 2025. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

Temasek Holdings reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
Temasek Holdings sold 520,900 Pfizer shares in Q3 2025, an estimated $12.6M.
Temasek Holdings first reported a position in Pfizer in Q1 2025 and held it in 2 quarters.
Temasek Holdings's Pfizer position peaked at $13.2M in Q1 2025.
2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Temasek Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.